Gsk Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gsk plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gsk Plc Today - Breaking & Trending Today

GSK faces whistleblower suit from lab that found Zantac risk | Jef Feeley & Anna Edney

GSK Plc. is facing a whistleblower lawsuit that could potentially cost it billions of dollars from the laboratory that revealed the presence of a probable carcinogen in Zantac, the heartburn medication that the UK drugmaker invented and turned into a blockbuster. An amended complaint filed Monday contends that GSK hid… ....

United States , New York , United Kingdom , Los Angeles , Brent Wisner , Jennifer Moore , Wisner Baum , Werner Baumann , International Agency For Research On Cancer , Us Justice Department , Drug Administration , Gsk Plc , Bayer Ag , Environmental Protection Agency , World Health Organization , Moore Law Group In Louisville , Connecticut Based Valisure , Moore Law Group , Chief Executive Officer Werner , International Agency ,

GSK plc (NYSE:GSK) Q1 2024 Earnings Call Transcript

GSK plc (NYSE:GSK) Q1 2024 Earnings Call Transcript May 4, 2024 GSK plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Nick Stone: Hello everyone. Welcome to today’s call and webcast. The presentation was sent to our distribution list by email, and […] ....

Aiolos Bio , Gsk Plc , Emma Walmsley ,

FTC challenges patents held by drugmakers, including for Ozempic

The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others. ....

United States , Joe Biden , Covis Pharma , Lina Khan , Commission On , Amphastar Pharmaceuticals , Boehringer Ingelheim , Drug Administration , Teva Pharmaceuticals , Novo Nordisk , Federal Trade Commission , President Joe Biden , Breaking News Politics , Breaking News , Amphastar Pharmaceuticals Inc , Teva Pharmaceutical Industries Ltd , Novartis Ag , Gsk Plc , Astrazeneca Plc , Novo Nordiska S , Social Issues , Products And Services , Health Care Industry , Biotech And Pharmaceuticals , Business News ,

Pfizer RSV vaccine may protect high-risk adults ages 18-59

Pfizer plans to file for an expanded approval of Abrysvo, which is currently approved for adults ages 60 and above and expectant mothers. ....

United States , Iona Munjal , Respiratory Syncytial Virus , Breaking News , Gsk Plc , Pfizer Inc , Health Care Industry , Biotech And Pharmaceuticals , Business News ,

Pfizer RSV shot trial shows protection for adults 18 to 59

There is currently no approved RSV vaccine for adults 18-59 years old ....

Drug Administration , Head Of Vaccine Research , Development Annaliesa Anderson , Senior Vice President , Vaccine Research , Rsv Vaccine , Gsk Plc , Ts Rsv Vaccine , Glaxosmithkline Gsk , Respiratory Syncytial Virus Vaccine , Oxford Astrazeneca Covid 19 Vaccine , Us Food And Drug Administration , Respiratory Syncytial Virus ,